US Bancorp DE grew its stake in shares of The Hain Celestial Group, Inc. (NASDAQ:HAIN – Free Report) by 10.3% during the 3rd ...

Fintel reports that on November 8, 2024, Stifel upgraded their outlook for Orthofix Medical (NasdaqGS:OFIX) from Hold to Buy. As of October 22, 2024, the average one-year price target for Orthofix ...

Stifel Financial Corp's robust wealth management division drives over 60% of net revenue. Active acquisition strategy bolsters Stifel's market presence and service offerings. Regulatory ...

Stifel Nicolaus analyst Alex Thompson CFA maintained a Buy rating on Spyre Therapeutics (SYRE – Research Report) yesterday and set a ...

Stifel downgraded Tempus AI (TEM) to Hold from Buy with a price target of $65, up from $45. The stock is up 100% since its debut and Tempus ...

November 05, 2024--(BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced today that its management team will present at the Stifel 2024 ...

Stifel Financial Corp. provides securities brokerage, investment banking, trading, investment advisory and related financial services. It operates through the following segments: Global Wealth ...

Stifel Financial's Q3 2024 financial performance ... buying earnings power at a discount in great companies like "Magic Formula" stocks, high-quality businesses, hidden champions and wide moat ...

(MENAFN- GlobeNewsWire - Nasdaq) 'Stifel North Atlantic AM-Forward' Earns SBA License & Leverage Capital As part of the final approval process, the Fund has earned a Small Business investment ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...